{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:47:11Z","timestamp":1791578831604,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2412035"],"award-info":[{"award-number":["W2412035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22474042"],"award-info":[{"award-number":["22474042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571707"],"award-info":[{"award-number":["32571707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20328"],"award-info":[{"award-number":["U22A20328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203041"],"award-info":[{"award-number":["82203041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32411530049"],"award-info":[{"award-number":["32411530049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1060000"],"award-info":[{"award-number":["XDB1060000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011408","name":"State Key Laboratory of Medicinal Chemical Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1475000"],"award-info":[{"award-number":["23ZR1475000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xcrm.2026.102709","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:18:09Z","timestamp":1774883889000},"page":"102709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A senescent tumor cell-derived nanovesicle directly primes splenic T cells to potentiate cancer radiotherapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Jiaxing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchentian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aojia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiji","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno G.","family":"De Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2673-4618","authenticated-orcid":false,"given":"Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102709_bib1","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.102709_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.trecan.2024.11.010","article-title":"Cellular senescence offers distinct immunological vulnerabilities in cancer","volume":"11","author":"Zhou","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","article-title":"Cellular senescence is immunogenic and promotes antitumor immunity","volume":"13","author":"Marin","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102709_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ccell.2025.05.015","article-title":"Senescence in cancer","volume":"43","author":"Colucci","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102709_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer - role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102709_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-025-02284-z","article-title":"Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s43018-023-00712-x","article-title":"The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2","volume":"5","author":"Chaib","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib9","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1016\/j.cell.2021.07.028","article-title":"Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer","volume":"184","author":"Ruscetti","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102709_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102709_bib11","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41556-024-01465-0","article-title":"p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells","volume":"26","author":"Majewska","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102709_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102709_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41556-021-00655-4","article-title":"Author Correction: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation","volume":"23","author":"Laberge","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102709_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s43018-023-00553-8","article-title":"EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance","volume":"4","author":"Chibaya","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102709_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41573-024-01126-9","article-title":"Enhancing immunity during ageing by targeting interactions within the tissue environment","volume":"24","author":"Bracken","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102709_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41573-024-01074-4","article-title":"Senescence as a therapeutic target in cancer and age-related diseases","volume":"24","author":"McHugh","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102709_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2024.05.002","article-title":"Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy","volume":"101","author":"Jiang","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2026.102709_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors","volume":"15","author":"Zhu","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2026.102709_bib21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/s41467-020-15719-6","article-title":"A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells","volume":"11","author":"Wakita","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102709_bib22","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2024.01.025","article-title":"Dual inhibition of CDK4\/6 and XPO1 induces senescence with acquired vulnerability to CRBN-based PROTAC drugs","volume":"166","author":"Wang","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102709_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2024.05.001","article-title":"p53\/MDM2 signaling pathway in aging, senescence and tumorigenesis","volume":"101","author":"Huang","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2026.102709_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","article-title":"Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging","volume":"169","author":"Baar","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102709_bib25","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809355","article-title":"A versatile drug delivery system targeting senescent cells","volume":"10","author":"Mu\u00f1oz-Esp\u00edn","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102709_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.devcel.2023.05.010","article-title":"Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies","volume":"58","author":"D'Ambrosio","year":"2023","journal-title":"Dev. Cell"},{"key":"10.1016\/j.xcrm.2026.102709_bib27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/acs.accounts.3c00794","article-title":"Chemical strategies for the detection and elimination of senescent cells","volume":"57","author":"Garc\u00eda-Fleitas","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.xcrm.2026.102709_bib28","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1038\/s41586-023-06088-3","article-title":"Author Correction: CAR immune cells: design principles, resistance and the next generation","volume":"619","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102709_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s43587-024-00576-5","article-title":"Unleashing CAR T cells to delay metabolic aging","volume":"4","author":"Bartley","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.xcrm.2026.102709_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/mabs.2.3.11782","article-title":"Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies","volume":"2","author":"Brennan","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2026.102709_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrc3057","article-title":"Pro-senescence therapy for cancer treatment","volume":"11","author":"Nardella","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102709_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib35","article-title":"Interferon-driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancer","volume":"6","author":"Huang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102709_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101661","article-title":"In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy","volume":"47","author":"Hou","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.xcrm.2026.102709_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102709_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrc.2016.154","article-title":"Targeting neoantigens to augment antitumour immunity","volume":"17","author":"Yarchoan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102709_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","article-title":"Harnessing innate immunity in cancer therapy","volume":"574","author":"Demaria","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102709_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120709","article-title":"Nanobiomaterial-based vaccination immunotherapy of cancer","volume":"270","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2026.102709_bib42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10599","article-title":"Senescence surveillance of pre-malignant hepatocytes limits liver cancer development","volume":"479","author":"Kang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102709_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10335-5","article-title":"Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition","volume":"10","author":"Pereira","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102709_bib44","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-21-0502","article-title":"Reprogramming cancer into antigen-presenting cells as a novel immunotherapy","volume":"13","author":"Linde","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102709_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005862","article-title":"Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells","volume":"11","author":"Liu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102709_bib46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2026.102709_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202001808","article-title":"Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity","volume":"32","author":"Jiang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.102709_bib48","article-title":"Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality","volume":"10","author":"Liu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102709_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s43587-023-00560-5","article-title":"Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction","volume":"4","author":"Amor","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.xcrm.2026.102709_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1951","article-title":"NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates","volume":"15","author":"Yang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102709_bib51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tcb.2024.06.007","article-title":"Immune surveillance of senescence: potential application to age-related diseases","volume":"35","author":"Wang","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102709_bib52","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s43587-024-00746-5","article-title":"Age-related decline in CD8(+) tissue resident memory T cells compromises antitumor immunity","volume":"4","author":"Pei","year":"2024","journal-title":"Nat. Aging"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:22:53Z","timestamp":1778919773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666379126001266"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102709","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A senescent tumor cell-derived nanovesicle directly primes splenic T cells to potentiate cancer radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102709"}}